cultivate (MD) Capital Funds Portfolio Company Virtual Incision Announces Approval to Complete Clinical Study Enrollment for its MIRA® Platform

FDA decision supported by an interim clinical study report on patient safety GRAND RAPIDS, Mich., Feb. 28, 2023 /PRNewswire/ — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that…

About the Author

has written 37715 stories on this site.

Copyright © 2010 Business and Corporate News.